Long-term maintenance of thromboxane inhibition by two different aspirin regimens in patients with unstable angina
- 1 October 1990
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 60 (2) , 169-175
- https://doi.org/10.1016/0049-3848(90)90295-n
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugsBlood, 1987
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Equal Antiplatelet Effects of Aspirin 50 or 324 mg/Day in Patients After Acute Myocardial InfarctionThrombosis and Haemostasis, 1985
- IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY)The Lancet, 1984
- Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose AspirinNew England Journal of Medicine, 1979
- The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.Journal of Clinical Investigation, 1975